Stem cell preparation for treating hepatic fibrosis

A stem cell preparation and liver fibrosis technology, applied in animal cells, vertebrate cells, bone/connective tissue cells, etc., can solve the problems of decreased proliferation and differentiation potential, inconsistent culture programs, and restrictions on large-scale use, so as to improve liver function. Functional status, not limited by ethics, and the effect of promoting liver pathological recovery

Active Publication Date: 2015-05-20
HANGZHOU S EVANS BIOSCI LTD
View PDF4 Cites 18 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the various types of mesenchymal stem cells that have been isolated and cultured, the number and proliferation and differentiation potential of bone marrow mesenchymal stem cells decrease with the age of the donor, and they are susceptible to virus infection during the isolation and culture process, which

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stem cell preparation for treating hepatic fibrosis
  • Stem cell preparation for treating hepatic fibrosis
  • Stem cell preparation for treating hepatic fibrosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1: Preparation of Menstrual Blood Stem Cell Injection

[0024] Collect menstrual blood samples from donors for routine microbial and infectious disease pathogen safety testing, use 1.0779 / ml Ficoll for density gradient centrifugation, and separate mononuclear cells from qualified samples, wash the isolated mononuclear cells 3 times with PBS, adjust Cell density to (3-5)×10 6 cells / ml, seeded on the bottom area of ​​75cm 2 Put in the culture flask of 37 ℃, 5% CO2 incubator expansion culture, use DMEM culture medium, the volume content is the double antibody culture medium of 1%, the volume content is 1% amphotericin B, the volume content is 1% gluten Incubate the cells with aminoamide and cell culture medium with a volume content of 20% fetal calf serum; after 48 hours of cell culture, digest with 0.25% trypsin-EDTA for 5 minutes, add an appropriate volume of complete medium to neutralize the activity of trypsin, and blow gently with a pipette , to suspend adhe...

Embodiment 2

[0027] Example 2: Establishment of mouse liver fibrosis model

[0028] ICR mice were intraperitoneally injected with CCl 4 (in l ml CCl 4 / kg dose injection containing 10% CCl 4 olive oil) to establish liver fibrosis model, injected twice a week for 4 consecutive weeks.

Embodiment 3

[0029] Example 3: Transplantation test of menstrual blood stem cells

[0030] Tail vein injection transplantation experiment: liver fibrosis model mice were divided into 3 groups, and l×10 6 cells / 100μl, 2×10 6 cells / 100μl and 4×10 6 Each cell / 100 μl cell dose, another injection of 100 μl PBS was used as a control, both were injected once. Maintain CCl during transplantation 4 Inject until mice are anesthetized and sacrificed for sampling.

[0031] Evaluation of the living conditions of the mice: the mice in the control group were active, their fur was shiny, and their diets were normal. The mice in the model group had reduced activity, dry fur, and reduced food intake. The mice in the treatment group became active gradually, their fur dryness decreased, and their food intake increased.

[0032]Liver function index: On the 28th day after cell transplantation, the mice in the model group, the control group and the transplantation group were anesthetized with ether and blo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a stem cell preparation for treating hepatic fibrosis, and a preparation method of the stem cell preparation. The stem cell preparation for treating hepatic fibrosis is prepared from human menstrual blood mesenchymal stem cells, a chemotactic factor CXCL8 and normal saline. The obtaining method of the menstrual blood mesenchymal stem cells is simple, free of ethical restriction, high in cell viability and high in proliferation capacity, has multi-directional differentiation potential and is simple and convenient to prepare. The menstrual blood mesenchymal stem cell preparation infusion technology provided by the invention is simple and convenient to operate; the hepatic fibrosis is treated by virtue of the menstrual blood mesenchymal stem cells; and the developed preparation method of the stem cell preparation for treating the hepatic fibrosis has very important clinical significance and wide application prospect.

Description

technical field [0001] The invention relates to the application of stem cells in disease treatment, in particular to the application of menstrual blood-derived mesenchymal stem cells in the treatment of liver fibrosis. Background technique [0002] Liver fibrosis is one of the pathological features of most end-stage liver diseases. If liver fibrosis is not treated effectively, it will eventually develop into liver cirrhosis and liver cancer, which seriously threaten the lives of patients. The essence of liver fibrosis is that collagen synthesis in the extracellular matrix increases and degradation decreases, resulting in excessive deposition of extracellular matrix in the liver, affecting the normal function of the liver. At present, it is believed that the mechanism of liver fibrosis is that liver cell injury and liver tissue inflammation activate Kupffer cells, liver cells, platelets or sinusoidal endothelial cells to secrete cytokines, lipid peroxides, etc. The substance...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K35/28A61P1/16C12N5/0775
Inventor 吴晓星刘广平项春生戴玲华
Owner HANGZHOU S EVANS BIOSCI LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap